Physician profile
Raed Hattab
NPI 1497701718
$2,596.20
in general payments reported to CMS, 2019-2025
9 companies · $1,694 in 2025
The $1,694 reported for 2025 was more than what 82% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $791 · 2024: $112 · 2025: $1,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525 · Travel and Lodging: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.45 |
| Travel and Lodging | $1,070.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,208.44 | 2025 | |
| Abbvie INC. | $400.28 | 2023-2024 | |
| Boston Scientific Corporation | $338.85 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $273.75 | 2023 | Intellis Adaptivestim, Vanta Adaptivestim |
| Gt Medical Technologies, INC | $161.97 | 2025 | Gammatile |
| Averitas Pharma INC. | $124.48 | 2023 | Qutenza |
| Curonix LLC | $37.53 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $34.24 | 2024 | Senza |
| Abbott Laboratories | $16.66 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raed Hattab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.